Lessons from the Pandemic: Mitigating Product Liability Risk in Supply Chains

In an era when intricately woven global networks dictate the pulse of commerce, supply chain issues have ascended as a critical focal point—particularly within the medical device industry. The turn of the decade brought us face-to-face with the fragility of supply chains: the COVID-19 pandemic, geopolitical tensions, and shifting trade policies have all cast long shadows over the stability of medical device manufacturing and distribution. As the industry grapples with these hurdles, the specter of product liability risk looms large—a topic demanding urgent discussion among those concerned with the uncertainty of the supply landscape.

As supply chains have shifted, some manufacturers have had to scramble to navigate the disruption as costs climb. Several reports have cited the soaring price of products, attributed largely to supply chain congestion and raw material cost inflation.1 Against this backdrop, the rise of product liability risk cannot be overstated. With increased pressure to deliver, some manufacturers grapple with the temptation to turn to alternative sources that may not meet their usual quality standards, inadvertently compromising the quality of finished products and raising the likelihood of product recalls or liability claims. In these times, stakeholders need to prioritize the formation of a robust risk management framework that hinges on a stringent adherence to quality assurance standards and disciplined oversight of supply chain members.

The purpose of this article is threefold: to dissect the threads of recent supply chain issues, to examine the resulting product safety implications, and to articulate risk mitigation strategies that can shield entities from product liability.

Legal Considerations and Product Liability Implications

In this section, legal considerations and product liability are covered, focusing on the significant roles suppliers play in shaping the product liability landscape for manufacturers and distributors. As we navigate through these complex legal waters, it is important to understand the intrinsic links between supply chain dynamics and product liability. This understanding is especially crucial in the medical device industry, where the repercussions of product defects can be severe, impacting both patient safety and the financial stability of the entities involved.

The concept of product liability centers around the legal responsibility that manufacturers, distributors, and suppliers bear for any injuries or damages caused by their products. In the context of medical devices, this liability is not only a matter of financial concern but also touches upon ethical considerations given the potential impact on healthcare outcomes. Suppliers play a pivotal role in product liability mitigation because the quality and reliability of the components they provide directly affect the safety and efficacy of the final medical device. Contract manufacturing organizations (CMOs) play a crucial role in ensuring component quality and reliability due to their specialized manufacturing expertise and stringent quality control processes, making them vital partners in mitigating product liability risks.

Supply chain issues can lead to product defects in several ways. For instance, variability in the quality of materials sourced from different suppliers can introduce inconsistencies in the manufacturing process, potentially leading to product failures. Additionally, logistical challenges, such as delays in the delivery of critical components or disruptions caused by geopolitical tensions and trade policies, can not only impact the timeliness of production but also force manufacturers to seek alternate suppliers, possibly compromising on quality for expediency. The COVID-19 pandemic has further highlighted how reliant the medical device industry is on a global and intricate supply network, with disruptions leading to shortages and, in some cases, hurriedly introduced products that may not have undergone the usual rigorous quality checks.

Manufacturers and distributors bear substantial legal responsibilities to ensure the safety and efficacy of their products. This duty is not only a matter of ethical business conduct but is enshrined in various international, federal, and state laws and regulations. Manufacturers and distributors must test their products rigorously, adhere to stringent quality control procedures, and remain vigilant in monitoring their supply chains to mitigate any risks that could lead to defects. Failure to fulfill these obligations can expose companies to significant legal liabilities, including product liability claims.

The past few years have provided salient examples of how supply chain issues can culminate in product liability claims. One notable case is the recall of several widely used blood pressure medications in 2018 and 2019. The recalls were triggered by the discovery of N-Nitrosodimethylamine (NDMA), an alleged human carcinogen, in the active pharmaceutical ingredients sourced from overseas manufacturers.2 This alleged contamination was attributed to changes in the manufacturing process of the impacted pharmaceuticals. Patients who had consumed these contaminated medications filed lawsuits against the manufacturers and distributors, alleging they failed to oversee their supply chains or warn about the risks of NDMA.

The legal implications of such product liability claims are profound. Companies found liable for distributing or manufacturing unsafe products, including components of finished products, can face compensatory damages to cover the costs of medical expenses, lost wages, and pain and suffering for the injured parties. In cases where the company’s conduct is found to be egregiously negligent or reckless, punitive damages may also be awarded.Moreover, the reputational damage ensuing from these lawsuits can impact consumer trust and shareholder value significantly, underscoring the far-reaching consequences of supply chain mismanagement.

Ensuring the integrity of your supply chain is a vital legal imperative. Manufacturers and distributors must adopt a proactive stance in managing their supply chains, deploying comprehensive risk assessment and mitigation strategies to prevent product defects.

Strategies for Risk Mitigation

In the dynamic landscape of the medical device industry, it is incredibly important to recognize the intrinsic role risk management plays in supply chain operations. Amid the backdrop of recent trends, the risk management framework becomes not merely a protocol but a necessity for safeguarding the integrity of supply chains. It is within this context that manufacturers are urged to enact robust strategies to minimize supply chain-related liability risks.

Supplier Selection and Oversight

Effective risk mitigation begins with rigorous due diligence processes. Companies that manufacture medical products, whether finished devices or their components, must vet supply chain members thoroughly, assessing their compliance with industry standards, their financial stability, and their capacity to deliver high-quality materials without fail. However, companies that do this well look beyond the basic requirements of FDA-mandated purchasing controls and put in place a rigorous supplier qualification protocol (see CFR 820.50). By maintaining a comprehensive understanding of the supply network, companies can better anticipate disruptions and implement contingency plans.

Supplier evaluation should extend beyond primary suppliers, ideally encompassing the entire supply chain to identify potential points of failure preemptively. It is important to understand that liability can arise from any supply chain member, not merely those “downstream” suppliers that occupy positions on the supply chain closest to the finished product. For example, consider the component supplier that contributes the defective hardware that ultimately causes the device installed in the surgical suite to collapse, injuring the patient and damaging expensive equipment. The company with its name on the device’s logo—the original equipment manufacturer (OEM)—can be held accountable for that component’s failure even though the company that provided the defective part was the supplier to the OEM’s supplier. The fact that liability can be shared among supply chain partners underscores the necessity of understanding who your supplier is doing business with and ensuring you vet that link in your supply chain as well as the next-tier supplier, and so on.

Quality control represents another cornerstone of risk mitigation. Continuous monitoring and testing of products at every stage—from raw materials through manufacturing to the final product—ensure any discrepancies are identified early, mitigated, and, where possible, prevented from recurring. For instance, CMOs can be instrumental in maintaining rigorous quality control standards, when they can leverage their advanced testing facilities and protocols to identify and mitigate discrepancies early in the manufacturing process. This collaborative approach to quality not only minimizes the risk of defective products reaching the market but also reinforces the overall commitment to uphold safety by both CMOs and OEMs.

OEMs that do supply chain surveillance well have a presence at their supplier’s manufacturing facilities to observe the manufacturing process and identify problems before they leave the supplier’s warehouse. They also test products, including through the use of third parties to examine and certify conformance. It can be important to understand what your supplier’s trending analysis reveals. What sort of issues is the supplier experiencing with their products as information from other customers and users reveals potential defects? Ultimately, a company’s ability to negotiate with its supplier for surveillance opportunities will determine the company’s strategy for monitoring that particular supplier. When bargaining power allows it, manufacturers should create opportunities to monitor and inspect their suppliers’ operations throughout the lifespan of their supply chain relationship.

Diversity in the Supply Chain

Diversifying the supply chain is yet another strategic measure that companies can adopt. By broadening their network of suppliers and logistical options, companies are not as severely impacted by regional disruptions, whether they stem from natural disasters, political unrest, or other unforeseen challenges. Diversification acts as a buffer, enhancing the resilience of the supply chain while allowing for greater flexibility in response to fluctuations in demand or supply constraints.

Regarding diversification, an OEM that has a “fallback” plan when a particular supplier cannot deliver product is less likely to seek out a replacement supplier it has not investigated fully or does not meet its quality standards. If the pandemic taught us anything, it is to have a plan to fill a supply chain gap before you need to do so. Relatedly, it is common in product liability to learn the defect that allegedly gave rise to the plaintiff’s injury occurred as a result of a new relationship with a supplier. It is this early part of the relationship with a new supplier when it is critical to ensure supplied parts are well-designed and manufactured for their intended use. Maintaining relationships with multiple suppliers provides a manufacturer the opportunity to identify and solve problems that can arise in new relationships before the manufacturer’s need for a supplied part or component is critical.

Liability Allocation

Legal tools that spread or allocate risk, including contracts and insurance, offer an additional layer of protection. Through carefully drafted agreements, companies can delineate the responsibilities and liabilities of each party explicitly, setting clear expectations regarding quality standards, delivery timelines, and contingency measures in the event of disruptions. Furthermore, insurance policies geared toward supply chain liabilities can provide a financial safety net, mitigating the economic impact of unforeseen setbacks.

Unfortunately, too many OEMs in the medical technology space do not contract with suppliers, meaning they miss an opportunity to ensure their supplier will retain any liability that arises from the supplier’s negligence. These OEMs also forgo the opportunity to influence the type and amount of insurance their suppliers can purchase to help mitigate the costs of product liability claims, should they arise. Companies that do contracting well ensure they have a contract in place with all of their first-tier suppliers. At a minimum, an OEM should conduct a risk and trending analysis to identify those supplied parts most likely to give rise to a product liability claim and ensure contracts are in place with the companies that provide those critical parts.

Conclusion

The combination of due diligence, quality control, supply chain diversification, and the strategic use of legal tools presents a comprehensive framework for medical device companies aiming to mitigate the risks associated with their supply chains. By implementing these practices, firms can navigate the complexities of the global supply network. This proactive stance not only safeguards the company’s interests but also upholds its commitment to delivering life-saving technologies to the global community. 

References

1. tinyurl.com/mpo240791
2. tinyurl.com/mpo240792

Sara Dyson, Esq., CPCU, is vice president of Underwriting Operations and Risk Management at Medmarc. Medmarc provides products liability insurance protection and related risk management services to medical technology and life sciences companies. Dyson holds a BA from the University of Michigan and a JD from the University of Wisconsin Law School. She is currently pursuing her MPH from the University of Missouri’s College of Health Sciences.

Zuhal Reed, Esq., is a life sciences attorney at Medmarc. She holds a BA and BS from the University of Toronto and a JD from the University of Utah, S.J. Quinney College of Law. Reed is currently pursuing her MS in Applied Biotechnology from the University of Wisconsin.